ENTRY       D11077                      Drug
NAME        Pegvaliase (INN);
            Pegvaliase (genetical recombination) (JAN);
            Pegvaliase-pqpz;
            Palynziq (TN)
PRODUCT     PALYNZIQ (BioMarin Pharmaceutical)
SEQUENCE    MKTLSQAQSK TSSQQFSFTG NSSANVIIGN QKLTINDVAR VARNGTLVSL TNNTDILQGI
            QASCDYINNA VESGEPIYGV TSGFGGMANV AISREQASEL QTNLVWFLKT GAGNKLPLAD
            VRAAMLLRAN SHMRGASGIR LELIKRMEIF LNAGVTPYVY EFGSIGASGD LVPLSYITGS
            LIGLDPSFKV DFNGKEMDAP TALRQLNLSP LTLLPKEGLA MMNGTSVMTG IAANCVYDTQ
            ILTAIAMGVH ALDIQALNGT NQSFHPFIHN SKPHPGQLWA ADQMISLLAN SQLVRDELDG
            KHDYRDHELI QDRYSLRCLP QYLGPIVDGI SQIAKQIEIE INSVTDNPLI DVDNQASYHG
            GNFLGQYVGM GMDHLRYYIG LLAKHLDVQI ALLASPEFSN GLPPSLLGNR ERKVNMGLKG
            LQICGNSIMP LLTFYGNSIA DRFPTHAEQF NQNINSQGYT SATLARRSVD IFQNYVAIAL
            MFGVQAVDLR TYKKTGHYDA RASLSPATER LYSAVRHVVG QKPTSDRPYI WNDNEQGLDE
            HIARISADIA AGGVIVQAVQ DILPSLH
  TYPE      Peptide
REMARK      Therapeutic category: 3999
            ATC code: A16AB19
            Product: D11077<JP/US>
EFFICACY    Antihyperphenylalaninemia
  DISEASE   Phenylketonuria [DS:H00167]
COMMENT     Phenylalanine ammonia lyase (PAL) derived from Anabaena variabilis
            Reduction of high blood phenylalanine concentrations caused by PAH deficiency
TARGET      PAH* [HSA_VAR:5053v1] [HSA:5053] [KO:K00500]
BRITE       Anatomical Therapeutic Chemical (ATC) classification [BR:br08303]
             A ALIMENTARY TRACT AND METABOLISM
              A16 OTHER ALIMENTARY TRACT AND METABOLISM PRODUCTS
               A16A OTHER ALIMENTARY TRACT AND METABOLISM PRODUCTS
                A16AB Enzymes
                 A16AB19 Pegvaliase
                  D11077  Pegvaliase (INN) &lt;JP/US&gt;
            USP drug classification [BR:br08302]
             Genetic, Enzyme, or Protein Disorder: Replacement, Modifiers, Treatment
              Pegvaliase
               D11077  Pegvaliase (INN)
            Therapeutic category of drugs in Japan [BR:br08301]
             3  Agents affecting metabolism
              39  Other agents affecting metabolism
               399  Miscellaneous
                3999  Others
                 D11077  Pegvaliase (INN); Pegvaliase (genetical recombination) (JAN)
            Target-based classification of drugs [BR:br08310]
             Enzymes
              Oxidoreductases (EC1)
               Other monooxygenases
                PAH* [HSA_VAR:5053v1]
                 D11077  Pegvaliase (INN) &lt;JP/US&gt;
            New drug approvals in the USA [br08319.html]
             New molecular entities and new therapeutic biological products
              D11077
            New drug approvals in Europe [br08329.html]
             European public assessment reports (EPAR) authorised medicine
              D11077
            New drug approvals in Japan [br08318.html]
             Drugs with new active ingredients
              D11077
            New drug approvals in the USA, Europe and Japan [br08328.html]
             Approval dates by FDA, EMA and PMDA
              D11077
            Pharmacogenomic biomarkers [br08341.html]
             Germline mutations in genetic disorder treatments
              D11077
DBLINKS     CAS: 1585984-95-7
            PubChem: 375581024
///
